Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 2,295 Shares of Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 2,295 shares of the firm's stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $59.55, for a total value of $136,667.25. Following the completion of the sale, the executive vice president directly owned 140,610 shares in the company, valued at $8,373,325.50. This trade represents a 1.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.